COVID-19 and Cardiology

Coronavirus disease 2019 (COVID-19), caused by a coronavirus strain known as severe acute respiratory syndrome coronavirus (SARS-CoV-2), has expanded over the world, affecting billions of humans. SARS-CoV-2 has several biological properties with SARS-CoV, the zoonotic virus that caused the severe acute respiratory syndrome epidemic, including the cell entrance pathway, which is triggered by the viral spike protein binding to angiotensin-converting enzyme. COVID-19 appears to be linked to even worse outcomes and an increased mortality risk in patients with well before cardiovascular disease, despite the fact that COVID-19 can cause myocardial injury, arrhythmias, acute coronary syndrome, and venous thromboembolism. Patients with COVID-19 and concomitant cardiovascular disorders are increasing concerned about potential drug–disease interactions.

    Related Conference of COVID-19 and Cardiology

    November 13-14, 2025

    6th Global Summit on Heart Congress

    Paris, France
    November 19-20, 2025

    7th World Heart Congress

    Tokyo, Japan
    November 24-25, 2025

    36th Annual Cardiologists Conference

    Barcelona, Spain
    November 27-28, 2025

    32nd World Heartcare Summit

    Paris, France
    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France
    March 23-24, 2026

    41st World Cardiology Conference

    London, UK
    April 08-29, 2026

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 13-14, 2026

    9th World Heart and Brain Conference

    Tokyo, Japan
    May 14-15, 2026

    5th International Conference on Cardiology

    Rome, Italy
    May 21-22, 2026

    15th World Congress on Cardiology

    London, UK
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France

    COVID-19 and Cardiology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in